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INTRODUCTION
Primary hyperparathyroidism (PHPT) is the third most 
common endocrine disorder in the United States, with an 
annual incidence of 100,000 new cases [1]. In the advanced 
industrialized world, PHPT is detected through a screening test. 
Accordingly, asymptomatic hypercalcemia is more prominent 
than symptomatic PHPT [2]. Previously, bilateral neck explo­
ration was considered the gold standard for the treatment of 
PHPT. However, with the advent of the sestamibi (MIBI) scan 
and radio­guided parathyroidectomy in the late 1990s, many 
groups advocated for a single­gland operation [3­6]. Fortunately, 
most PHPT cases are due to single adenomas. Although focused 
parathyroidectomy (FP) has been the preferred treatment of 
PHPT, advocates of conventional parathyroidectomy (CP) have 
continued to debate the efficacy of CP relative to that of FP. 
Although in most cases a single adenoma is found, double ade­
nomas and multiglandular disease (MGD) have been reported 
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at rates of 4% and 14%, respectively [7]. Recently, the leading 
group advocating unilateral parathyroidectomy has abandoned 
unilateral exploration and reversed its position on CP due to 
the high recurrence rate (FP 5% vs. CP 0.6% at 10 years) [8].
However, the incidence of PHPT has differed according to 
race, with the highest rates among blacks, followed by whites, 
and the lowest rates among Asians (prevalence of 321 vs. 201 vs. 
103 per 100,000, respectively) [9]. It has also been reported that 
multiple parathyroid lesions were rare in Asians when PHPT 
was diagnosed [9­11]. 
In addition, we have also recognized two discrete forms, 
such as asynchronous and synchronous MGD [12]. Preoperative 
localization studies have been more successful due to the 
advent of sensitive imaging techniques, thus allowing pre­
determination of single or multiple gland involvement [13­19]. 
Consequently, we hypothesized that FP may be an operation 
method that offersh a high success rate in PHPT. The aim of 
this study was to determine whether CP or FP is appropriate 
and to compare follow­up data in PHPT.
METHODS
This study was approved by the Yonsei University 
Institutional Review Board (approval number: 4­2014­0015). 
The need for informed consent was waived because of the 
retrospective nature of the study. We retrospectively analyzed 
225 operations for PHPT at Yonsei University Health System 
between 2000 and 2012. Ninety­three cases met the exclusion 
criteria, and 30 cases were excluded owing to multiple 
endocrine neoplasm, familial isolated hyperparathyroidism, 
pending chronic re nal failure, parathyroid cyst, or parathyroid 
carcinoma. Fur thermore, 51 cases were excluded owing to 
concomitant thyroid disease requiring thyroidectomy, and 12 
cases were excluded owing to an incomplete preoperative study 
(Fig. 1). All patients underwent preoperative ultrasonography 
(USG) and a MIBI scan, and all pathology­based diagnoses were 
confirmed histopathologically after the operation. We did not 
use intraoperative parathyroid hormone (PTH) monitoring. 
Instead, we assessed postoperative PTH levels within 2 hours 
after the operation. A total of 132 patients were divided into 
2 groups according to the operation method: those who 
underwent FP (n = 122) and those who underwent CP (n = 
10). The FP group included minimally invasive radio­guided 
parathyroidectomy and endoscopic parathyroidectomy. We 
compared the clinicopathological features, including symptoms 
and signs; preoperative calcium, PTH, phosphorus, vitamin D, 
24­hour urine calcium, and ALP levels; postoperative calcium 
and PTH levels; pathologic diagnosis; multiplicity; and results 
of the localization study. Recurrence was defined as elevated 
calcium and PTH occurring after 6 months postoperatively. 
Fig. 1. Characteristics of the 
cases ex cluded. PHPT, primary 
hyperparathyroidism; CRF, chro­
nic renal failure; MEN, mul tiple 
endocrine neoplasia; HPT, hyper­
parathyroidism; MIBI, sestamibi; 
USG, ultrasonography.
225 Patients for PHPT
51 Concomitant thyroid disease
30 Thyroid cancer
20 Thyroid nodule
12 Parathyroid cyst
2 Parathyroid carcinoma
4 Pending CRF
12 Inherited parathy oid disease
10 MEN 1
1 MEN 2a
1 Familial isolated HPT
r
12 Incomplete imaging study
(no preceding MIBI scan)
132 Enrolled patients
How many parathyroid lesion are detected using
preoperative localization studies (MIBI scan and USG)?
122 Focused parathy oidectomyr
Single
10 Conventional parathyroidectomy
Multiple
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Persistence was defined as elevated calcium and PTH within 6 
months postoperatively [20].
Data are expressed as mean ± standard deviation. The Fisher 
exact test or Pearson chi­square test was used to compare 
clinicopathological findings in FP and CP groups. Statistical 
analysis was performed using IBM SPSS Statistics ver. 20.0 
(IBM Co., Armonk, NY, USA), and differences were considered 
significant when P­values were less than 0.05.
RESULTS
There were no differences in symptomatic characteristics 
between FP and CP groups (Table 1). About 60%–65% of cases 
were asymptomatic. Age was significantly higher in the CP 
group compared to that in the FP group, but there were no 
differences in demographic and laboratory characteristics bet­
ween FP and CP groups for sex, follow­up period, presence of 
symptoms, preoperative serum calcium, preoperative PTH, pre­
operative serum phosphate and ALP levels, and preoperative 
bone mineral density. Operation time was shorter in the FP 
than that in the CP group. Our study contained a variable 
follow­up period, with some patients followed for almost 12 
years. The mean follow­up time was about 46 months in the FP 
group and 59 months in the CP group (Table 2).
There was one failed preoperative localization using both USG 
and MIBI in the FP group. However, this failed localization was 
followed by a successful additional magnetic resonance study. 
Our study showed that sensitivity in detecting parathyroid 
lesions was 94.3% using MIBI scans and 90.2% using USG. Of 
the 122 patients in the FP group, only 103 patients were positive 
using both USG and the MIBI scan; 7 patients were positive 
only in the USG study, and 12 patients were positive only in 
the MIBI study. Therefore, almost all parathyroid lesions were 
localized using a combination of USG and the MIBI scan (Table 
3).
There was no significant difference between the 2 groups 
for postoperative calcium, PTH level, or size and weight of 
the parathyroid specimen. A large percentage (95.5%) of all pa­
tients with PHPT had a single parathyroid lesion. MGD was 
un common in all cases (6 of 132, 4.5%). In all cases of multiple 
para thyroid lesions identified in the preoperative localization 
study, we preferred CP due to the possibility of MGD or double 
adenoma. However, of the 10 CP patients, four underwent CP 
owing to another USG­detected ambiguous parathyroid lesion 
that was confirmed using a frozen biopsy. In these cases, 
disease in only a single parathyroid gland was reported at the 
final pathology. 
There was no significant difference in the rate of failed sur­
Won Woong Kim, et al: USG and MIBI to detect hyperparathyroidism
Table 1. Characteristic symptoms and signs of primary hy­
per parathyroidism
Symptom and sign FP (n = 122) CP (n = 10)
Asymptomatic (hypercalcemia based 
on a screening test)
80 (65.6) 6 (60.0)
Symptomatic 42 (34.4) 4 (40.0)
   Bone pain/osteoporosis 18 (14.8) 1 (10.0)
   Renal or ureter stone 12 (9.8) ­
   Fatigue/general weakness 9 (7.4) 2 (20.0)
   Gastroduodenal ulcer 5 (4.1) ­
   Palpable neck mass 3 (2.5) 1 (10.0)
   Itching and aching pain, hot flush 5 (4.1) ­
Values are presented as number (%).
FP, focused parathyroidectomy; CP, conventional parathyroidec­
tomy.
Table 2. Preoperative demographics and clinical data bet ween focused parathyroidectomy and conventional para thy roi dec­
tomy groups
Variable FP (n = 122) CP (n = 10) P­value
Age (yr) 50.8 ± 13.0 61.1 ± 9.7 0.016
Sex, female:male 94:28 6:4 0.255
Follow­up period (mo) 45.5 ± 42.2 58.7 ± 46.2 0.345
Presence of symptoms 42 (34.4) 4 (40.0) 0.722
Preoperative calcium (mg/dL) 11.9 ± 1.4 11.7 ± 1.5 0.733
Preoperative PTH (pg/mL) 212.1 ± 238.9 184.6 ± 116.0 0.720
Preoperative phosphorus (mg/dL) 2.7 ± 0.6 2.8 ± 0.8 0.454
Vitamin D (25(OH)D) (ng/mL) 12.3 ± 8.4 11.2 ± 5.9 0.740
ALP (IU/L) 134.6 ± 96.0 80.1 ± 35.0 0.077
24­hr urine calcium (mg/day) 330.3 ± 295.0 268.5 ± 193.7 0.684
BMD (T­score) –2.6 ± 1.1 –2.1 ± 1.1 0.266
Values are presented as mean ± standard deviation or number (%). 
Reference values for our institution: calcium, 8.6–10.6 mg/dL; PTH, 15–65 pg/mL; phosphorus, 2.3–4.5 mg/dL; vitamin D (25(OH)D), 
>30 ng/mL; ALP, 120–360 IU/L; 24­hr urine calcium, 50–200 mg/day.
FP, focused parathyroidectomy; CP, conventional parathyroidectomy; PTH, parathyroid hormone; BMD, bone mineral density (T­score 
from L­spine).
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gery between the 2 groups (FP 0.8% vs. CP 10.0%, P = 0.146). 
Post operative persistent hyperparathyroidism developed in 
one FP patient and one CP patient due to technical failure. All 
MGD cases were diagnosed using the preoperative localization 
study. There was no significant difference in the sizes or 
weights of specimens between the 2 groups. However, the rate 
of hyperplasia was higher in the CP group than in the FP group 
(50% vs. 12.3%, P = 0.02) (Table 4). 
In the 2 cases of persistent hyperparathyroidism, the postop­
erative PTH level exceeded the upper limit of the normal range. 
Case 1
A 65­year­old male (sCa 12.2 mg/dL, PTH 88.2 pg/mL) 
underwent right superior and left superior parathyroidectomy. 
Postoperatively, sCa (10.6 mg/dL) and PTH (75.2 pg/mL) were 
still elevated. One right superior parathyroid hyperplasia and 
one left superior lymph node in one CP patient were reported at 
the final pathology. The patient denied the proposed additional 
re­operation.
Case 2
A 63­year­old female (sCa 11.1 mg/dL, PTH 300 pg/mL) 
underwent right inferior parathyroidectomy. Postoperatively, 
sCa (9.4 mg/dL) and PTH (151 pg/mL) were checked. One para­
thyroid tissue in one FP patient was reported at the final patho­
logy. Ten months after initial operation, she was cured after 
resection of right inferior parathyroid adenoma. 
In the 2 failed surgery cases, an additional localization study 
such as methionine PET­CT, selective venous sampling, or USG­
guided indigo carmine tattooing was used for reoperation. 
After the preceding additional localization study, 2 patients had 
re­exploration after a previous procedure failed to locate and 
remove an abnormally functioning parathyroid gland. After 
Table 3. Comparison of preoperative localization studies 
bet ween focused parathyroidectomy and conventional para­
thyroidectomy groups
Preoperative study FP (n = 122) CP (n = 10) P­value
USG
  Positive 110 (90.2) 9 (90.0) 0.987
  Negative 12 (9.8) 1 (10.0)
MIBI
  Positive 115 (94.3) 10 (100) 0.436
  Negative 7 (5.7) 0 (0)
Values are presented as number (%).
FP, focused parathyroidectomy; CP, conventional para thy roi dec­
tomy; USG, ultrasonography; MIBI, sestamibi. 
Table 4. Comparison of postoperative characteristic findings
Variable FP (n = 122) CP (n = 10) P­value
Operation time (min) 52.0 ± 19.1 94.5 ± 30.8 0.001
Postoperative calcium (mg/dL)
  Within 2 hours after surgery 9.2 ± 0.9 9.1 ± 1.0 0.862
  6 Months after surgery 9.27 ± 0.5 9.3 ± 0.7 0.846
Postoperative PTH (pg/mL)
  Within 2 hours after surgery 19.0 ± 21.8 25.6 ± 28.1 0.373
  6 Months after surgery 35.4 ± 20.8 40.8 ± 25.8 0.469
Parathyroid lesion 0.001
  Single lesion 122 (100) 4 (40.0)
  Right superior:left superior 17:20 0:1
  Right inferior:left inferior 47:38 2:1
Multiple lesion 0 (0) 6 (60.0)
Unilateral 0 (0) 1 DA
Bilateral 0 (0) 5 (MGD 2, DA 3)
Pathology 0.002
  Adenoma 107 (87.7) 5 (50.0)
  Hyperplasia 15 (12.3) 5 (50.0)
  Size (mm) 19.3 ± 8.9 21.4 ± 13.9 0.497
  Weight (mg) 2,354 ± 2,969 3,200 ± 812 0.574
Failed surgery 0.146
  Persistent 1 (0.8) 1 (10.0)
  Recurrent 0 (0) 0 (0)
Values are presented as mean ± standard deviation or number (%). 
Reference values for our institution: calcium, 8.6–10.6 mg/dL; PTH, 15–65 pg/mL.
FP, focused parathyroidectomy; CP, conventional parathyroidectomy; PTH, parathyroid hormone; DA, double adenoma; MGD, multi­
glandular disease.
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removal of the abnormal gland, all patients became normo­
calcemic, and the PTH level decreased below the upper limit of 
the normal range.
DISCUSSION
Before advances in preoperative localization studies and 
intraoperative PTH analysis, bilateral exploration was consi­
dered the gold standard treatment of PHPT because of the 
possi bility of MGD. However, with improved understanding 
of the disease pattern in PHPT, unilateral approaches have 
emerged with high cure rates. Nonetheless, Duh et al. [7] 
reported that unilateral exploration was associated with a risk 
of missing a contralateral double adenoma with or without 
a localization study. Despite the possibility of MGD, many 
groups have advocated for using a single­gland operation 
such as radio­guided or FP [3­6,21]. Before the first application 
of minimally invasive FP in 2001, we performed 32 radio­
guided parathyroidectomies beginning in 1999. Our previous 
initial study showed that minimally invasive radio­guided 
parathyroidectomy and minimally invasive FP achieved a high 
success rate compared with bilateral or unilateral exploration 
[22]. Among the 122 patients with FP who were enrolled in 
this study, only 9 underwent radio­guided parathyroidectomy. 
Accordingly, Radio­guided parathyroidectomy could not have 
influenced our results. This study had somewhat descriptive 
nature, making it difficult to identify significant differences 
between FP and CP. As more data have become available, there 
has been a gradual evolution of the operation method used to 
avoid recurrence. About 10 years ago, we confirmed that FP is 
sufficient to treat PHPT due to the advent of sensitive imaging 
techniques such as high­resolution USG that are used for 
preoperative localization studies [22].
Furthermore, the group of Norman et al. [8]—the leading 
group advocating unilateral parathyroidectomy—have recently 
abandoned this position and reversed their position toward 
CP. They showed that the recurrence rate after unilateral para­
thyroidectomy was significantly higher than that after bila­
teral operation. Nevertheless, it is possible that the authors 
might have missed false negative parathyroid lesions in 
the parathyroid scan, because they only used MIBI scan. 
Consequently, surgical controversies are more complicated in 
PHPT, and there was a need to confirm treatment of PHPT 
using long­term follow­up data. It is notable that MGD was un­
common in our study and that cure rates were as high as 98.5%, 
with an especially high rate of 99.2% in the FP group (Table 5).
In addition, some groups have reported that microscopically 
hyperplastic glands of normal size are of no clinical significance 
and that the removal of such glands is unnecessary [23]. After 
experienced surgeons inspected ambiguous parathyroid lesions 
in patients with MGD and double adenoma, they decided 
whether a frozen biopsy should be performed. Even though 
we used frozen biopsies to confirm pathology, some of the 
pathologic reports did not provide enough information to 
obtain a precise determination of whether the parathyroid 
lesion included pathological change. Although histologic 
differences between adenomas and hyperplastic glands have 
been proposed, the diagnosis of single­gland disease versus 
Won Woong Kim, et al: USG and MIBI to detect hyperparathyroidism
Table 5. Comparison of cure rates between procedures
Study Operative procedure No. of patients Preoperative studies IoPTH Cure rate (%)
Chen et al. [3] (1999) MIP 33 Sestamibi­SPECT (+) 100
BE 184 (+) 97.3
Udelsman [21] (2002) MIP 255 Sestamibi (+) 99.0
BE 401 (+) 98.0
Yoon et al. [22] (2004) BE+UE 60 Sestamibi (–) 96.7
MIRP 31 Sestamibi (–) 96.8
MIFP 27 USG + Sestamibi (–) 96.3
Lee et al. [10] (2008) BE 70 USG + Sestamibi (–) 100
UE 34 (–) 100
MIP 75 (–) 98.7
Elaraj et al. [25] (2010) BE 153 USG + Sestamibi (+) 91.5
FP +UE 339 (+) 98.2
Norman et al. [6] (2010) BE 2,048 Sestamibi (+) 99.9
UE 952 (+) 99.0
Gill et al. [18] (2011) BE 62 USG + Sestamibi (+) 98.0
UE 14 (+) 100
Kim et al. 2016 (present study) FP 122 USG + Sestamibi (–) 99.2
CP 10 (–) 90.0
BE, bilateral exploration; UE, unilateral exploration; SPECT, single photon emission computerized tomography; MIRP, minimal invasive 
radio­guided parathyroidectomy; MIFP, minimal invasive focused parathyroidectomy; IoPTH, intraoperative parathyroid hormone.
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four­gland hyperplasia has traditionally been made using a 
combination of gross surgical and histologic findings. On the 
other hand, a Wisconsin group suggested that parathyroid 
gland weight helps to predict the likelihood of an additional 
hyperfunctioning parathyroid gland [24]. In this regard, high­
resolution USG is very useful and can supplement MIBI scans, 
which do not precisely measure parathyroid size. Elaraj et al. 
[25] suggested additional imaging using neck USG is helpful 
for selecting minimally invasive parathyroidectomy in most 
patients with PHPT who have negative MIBI scan results. We 
decided to perform FP in both of the following situations: 
when USG and MIBI scan findings were discordant in unilateral 
location, and when there was single positive lesion on both 
the USG and MIBI scan. However, when USG and MIBI scan 
findings were discordant in bilateral location, we decided to 
perform CP. Our results showed that USG is useful when MIBI 
scans are negative and that it may also be useful when tattooing 
a parathyroid lesion in failed surgery. 
Nonetheless, reoperation for recurrent PHPT was associated 
with higher failure rates and complications, especially in CP 
cases. The occurrence of asynchronous MGD has been re­
ported after an initially successful operation. Worsey et al. 
[12] reported an average recurrent­free period of 3.8 years after 
a successful operation with 15 years of follow­up. Because 
of the possibility of asynchronous MGD, using FP to avoid 
unnecessary dissection is more beneficial than CP in recurrent 
cases. Patients who are not cured after such an approach are 
able to undergo a simple, noncomplex, second operation that is 
performed in naïve tissues [8].
Our study has limitations. First, the follow­up period for 
this series was different for each patient (6–160 months). In 
addition, the incidence of PHPT in Korea is lower than in 
America and Europe. Moreover, we did not use intraoperative 
PTH monitoring; instead, we checked postoperative PTH within 
2 hours postoperatively. In spite of these limitations, we have 
previously reported that there was a gradual evolution of the 
operation method used to avoid recurrence at our institution 
over about 24 years [22]. 
Ning et al. reported that elevated PTH after successful para­
thyroidectomy for PHPT is not associated with recurrent 
hyper parathyroidism [26,27]. Many studies have reported that 
intraoperative PTH monitoring is useful in successful para­
thyroidectomy for PHPT [28,29]. In some cases, intraoperative 
PTH monitoring is thought to confuse the decision­making 
process [27,30]. Furthermore, undetected hyperplastic glands of 
normal size in the preoperative imaging study are of no clinical 
significance, and the removal of such glands is unnecessary [23].
In conclusion, FP is appropriate in cases of a single lesion 
confirmed preoperatively. Consequently, we suggest FP is 
more appropriate than CP for PHPT, except for cases in which 
MGD is detected in the preoperative imaging study. Improved 
preoperative localization studies such as high­resolution USG 
and additional knowledge regarding hereditary PHPT may help 
to determine whether FP or CP should be performed for all 
cases in which the localization study has unilateral results. 
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